Browse > Article
http://dx.doi.org/10.15269/JKSOEH.2020.30.2.196

Influencing Factors of Plasma Levels of Total Peroxide and Oxidative Stress Index in Retired Miners with Chronic Obstructive Pulmonary Disease  

Lee, Jong Seong (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service)
Shin, Jae Hoon (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service)
Baek, Jin Ee (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service)
Jeong, Ji Yeong (Department of Medical Biotechnology, Dong-A University)
Choi, Byung-Soon (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service)
Publication Information
Journal of Korean Society of Occupational and Environmental Hygiene / v.30, no.2, 2020 , pp. 196-204 More about this Journal
Abstract
Objective: Chronic obstructive pulmonary disease(COPD) is characterized by persistent airflow limitations associated with chronic inflammatory response due to noxious particles or gases in the lung. Increasing oxidative stress associated with COPD. The aim of this study was to evaluate the influencing factors of biomarkers for oxidative stress in retired miners with COPD. Methods: The levels of total peroxide(TPx), total antioxidant capacity(TAC), and oxidative stress index(TPx/TAC ratio, OSI) in plasma as biomarkers for oxidative stress, serum C-reactive protein(CRP) as a biomarker for inflammation, and general characteristics were measured in 93 male subjects with COPD. COPD was defined as post bronchodilator FEV1/FVC<0.7 by spirometry. Results: Mean levels of TPx(p=0.013), TAC(p=0.010), OSI(p=0.040), and CRP(p=0.024) were higher in current smokers. Levels of TPx(β=0.445, p<0.001), TAC(β=0.490, p<0.001), and OSI(β=0.351, p<0.001) were related to CRP levels, and CRP levels were related to %FEV1 predicted(β=-0.295, p=0.003) and current smoking(β=0.214, p=0.032). Conclusions: These results suggest that oxidative stress was related to inflammation, and inflammation were related to decreasing %FEV1 predicted and current smoking in retired miners with COPD.
Keywords
Chronic obstructive pulmonary disease; C-reactive protein; oxidative stress index; retired miner; total peroxide;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Fukui T, Yamauchi K, Maruyama M, Yasuda T, Kohno M et al. Significance of measuring oxidative stress in lifestyle-related diseases from the viewpoint of correlation between d-ROMs and BAP in Japanese subjects. Hypertens Res 2011;34(9):1041-1045 PMID:19403985   DOI
2 Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta analysis. Thorax 2004;59:574-580 http://doi.org/10.1136/thx.2003.019588   DOI
3 Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338 http://doi.org/10.1183/09031936.05.00034805   DOI
4 Morimoto M, Satomura S, Hashimoto T, Ito E, Kyotani S. Oxidative stress measurement and prediction of epileptic seizure in children and adults with severe motor and intellectual disabilities. J Clin Med Res 2016;8(6):437-444 http://doi.org/10.14740/jocmr2534w   DOI
5 Pepys MB & Hirschfield GM. "C-reactive protein: a critical update". J Clin Invest 2003;111:1805-1812 http://doi.org/10.1172/JCI18921   DOI
6 Porter DW, Hubbs AF, Mercer R, Robinson VA, Ramsey D et al. Progression of lung inflammation and damage in rats sfter cessation of silica inhalation. Toxicol Sci 2004;79:370-380 http://doi.org/10.1093/toxsci/kfh110   DOI
7 Repine JE, BAST A, Lankhorst I, The Oxidative stress study group. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156(2 Pt 1):341-357 http://doi.org/10.1164/ajrccm   DOI
8 Schins RPF & Borm PJA. Mechanisms and mediators in coal dust induced toxicity: A review. Am Occup Hyg 1999;43(1):7-33 PMID:10028891   DOI
9 Singh S, Verma SK, Kumar S, Ahmad MK, Nischal A et al. Evaluation of oxidative stress and antioxidant status in chronic obstructive pulmonary disease. Scand J Immunol 2017;85(2):130-137 http://doi.org/10.1111/sji.12498   DOI
10 Gulumian M, Borm PJA, Vallyathan, Castranova V, Donaldson K et al. Mechanistically identified suitable biomarkers of exposure, effect, and susceptibility for silicosis and coal-worker's pneumoconiosis: a comprehensive review. J Toxicol Environ Health, Part B 2006;9:357-395 http://doi.org/10.1080/15287390500196537   DOI
11 Karadag F, Kirdar S, Karul AB, Ceylan E. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med 2008;19:104-108 http://doi.org/10.1016/j.ejim.2007.04.026   DOI
12 Hanta I, Kocabas A, Canacankatan N, Kuleci S, Seydaoglu G. Oxidant-antioxidant balance in patients with COPD. Lung 2006;184(2):51-55 http://doi.org/10.1007/s00408-005-2561-4   DOI
13 Hirose H, Kawabe H, Komiya N, Saito I. Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb 2009;16(2):77-82 http://doi.org/10.5551/jat.e265   DOI
14 Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174: 867-874 http://doi.org/10.1164/rccm.200604-506OC   DOI
15 KATRD(Korean academy of tuberculosis and respiratory diseases). Guideline for COPD and asthma. Seoul: Seoul Medcus; 2005. p. 26-27
16 Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S: Oxidative stress in expired breath condensate of patients with COPD. Chest 2003; 124(4):1373-1380 PMID:14555568   DOI
17 Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O et al. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J 2009;34:634-640 http://doi.org/10.1183/09031936.00167708   DOI
18 Su B, Liu T, Fan H, Chen F, Ding H et al. Inflammatory markers and the risk of chronic obstructive pulmonary disease: A systematic review and metaanalysis. PLoS One 2016;11:E0150586 http://doi.org/10.1371/journal.pone.0150586   DOI
19 Tkacova R, Kluchova Z, Joppa P, Petrasova D, Molcanyiova A. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir Med 2007;101(8):1670-1676 http://doi.org/10.1016/j.rmed.2007.03.005   DOI
20 Taylan M, Demir M, Kaya H, Selimoglu Sen H, Abakay O et al. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients. Clin Respir J 2017;11:311-317 http://doi.org/10.1111/crj.12336   DOI
21 Mak JC. Pathogenesis of COPD. Part II. Oxidative antioxidative imbalance. Int J Tuberc Lung Dis 2008;12(4):368-374 PMID:18371260
22 Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011;139(4):752-763 http://doi.org/10.1378/chest.10-1253   DOI
23 Larsson K. Aspects on pathophysiological mechanisms in COPD. J Intern Med 2007;262(3):311-340 http://doi.org/10.1111/j.1365-2796.2007.01837.x   DOI
24 Lee JS, Shin JH, Baek JE, Jeong JY, Choi BS. Inflammation and oxidative stress as related to airflow limitation severity in retired miners with chronic obstructive pulmonary disease. J Kor Soc Occup Environ Hyg 2019:29(2):251-258 https://doi.org/10.15269/JKSOEH.2019.29.2.251   DOI
25 Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2095-2128 http://doi.org/10.1016/S0140-6736(12)61728-0   DOI
26 MacNee W. Oxidants and COPD. Curr Drug Targets Inflamm Allergy 2005;4(6):627-41 http://doi.org/10.2174/156801005774912815   DOI
27 Meijers JM, Swaen GM, Slangen JJ. Mortality of Dutch coal miners in relation to pneumoconiosis, chronic obstructive pulmonary disease, and lung function. Occup Environ Med 1997;54(10):708-713 PMID: 9404317   DOI
28 Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PLoS One 2012;7:E37483 http://doi.org/10.1371/journal.pone.0037483   DOI
29 Agusti AG, Noguera A, Sauleda J, Sala E, Pons J et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-360 http://doi.org/10.1183/09031936.03.00405703   DOI
30 Anderson SC & Cockayne S. Clinical Chemistry. Concepts & applications. New York, The McGraw-Hill Co.; 2003. p. 285-96
31 Babior BM. NADPH-oxidase: an update. Blood 1999; 93(5):1464-1476 PMID:10029572   DOI
32 Barany T, Simon A, Szabo G, Benko R, Mezei Z et al. Oxidative Stress-Related Parthanatos of Circulating Mononuclear Leukocytes in Heart Failure. Oxid Med Cell Longev 2017;1249614 http://doi.org/10.1155/2017/1249614
33 Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56(4):515-48 http://doi.org/10.1124/pr.56.4.2   DOI
34 ben Anes A, Fetoui H, Bchir S, ben Nasr H, Chahdoura H et al. Increased oxidative stress and altered levels of nitric oxide and peroxynitrite in Tunisian patients with chronic obstructive pulmonary disease: correlation with disease severity and airflow obstruction. Biol Trace Elem Res 2014;161(1):20-31 http://doi.org/10.1007 s12011-014-0087-4   DOI
35 Bergdahl IA, Tore'n K, Eriksson K, Hedlund U, Nilsson T et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J 2004;23:402-406 http://doi.org/10.1183/09031936.04.00034304   DOI
36 Chen YW, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of COPD exacerbation. PLoS One 2016;11:E0158843 http://doi.org/10.1371/journal.pone.0158843   DOI
37 Choi JK, Paek DM, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis 2005;58:230-242 http://dx.doi.org/10.4046/trd.2005.58.3.230   DOI
38 Coggon D & Anthony Newman TA. Coal mining and chronic obstructive pulmonary disease: a review of the evidence. Thorax 1998;53:398-407 PMID:9708233   DOI
39 Fabbri LM & Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370:797-799 http://doi.org/10.1016/S1473-3099(19)30281-6   DOI